EcoDrugPlus

Prostaglandin E Receptor 2

Ensembl ID : ENSMMNG00015016185
Gene Symbol: PTGER2
1 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSMMNG00015004807
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSMMNG00015003808
Gene Symbol: PTGER4
3 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSMMNG00015007927
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSMMNG00015008294
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSMMNG00015018448
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSMMNG00015020023
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSMMNG00015020868
Gene Symbol: PSMA1
3 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSMMNG00015012176
Gene Symbol: PSMA2
3 Cross references
228 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSMMNG00015010058
Gene Symbol: PSMA3
1 Cross references
234 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMMNG00015011092
Gene Symbol: PSMA4
3 Cross references
248 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMMNG00015020583
Gene Symbol: PSMA5
3 Cross references
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).